Comparison 1. Transurethral radiofrequency collagen denaturation versus no treatment/sham treatment.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Serious adverse events	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
2 Disease‐specific quality of life: number of women with an I‐QOL score improvement ≥ 10 points at 12 months	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
3 Clinician observations: objective measurement of incontinence: change in leak point pressure at 12 months	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
4 Other adverse event: pain/dysuria: dysuria	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
5 Other adverse event: (new) detrusor overactivity: overactive bladder symptoms	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
6 Other adverse event: de novo urinary retention: urinary retention	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
7 Other adverse event: urinary tract infection	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
8 Other adverse event: haematuria	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
9 Other adverse event: hesitancy	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected